About AMAG Pharma
AMAG Pharma is a Healthcare company based in Waltham (United States) founded in 1981, and was acquired by Covis Pharma in October 2020. Manufacturer of anemia based products and imaging agents for cancer and CVD diagnosis. AMAG Pharma has completed 4 acquisitions, including Cord Blood Registry, Lumara Health and Perosphere. AMAG Pharma offers products and services including Alvesco and Feraheme. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Covis Pharma GmbH.
Company details
AMAG Pharma was founded in 1981 and is headquartered in Waltham, United States. Operations focus on the pharmaceutical sector, where anemia-based products and diagnostic imaging agents are developed and commercialized. A therapeutic iron compound is produced to address iron deficiency anemia, alongside agents for cancer and cardiovascular disease diagnosis. Two approved products, Feraheme injection for intravenous use and GastroMARK, are manufactured and distributed.
- Headquarters Waltham, United States
- Stage Acquired
- SectorsHealthcare
- Website amagpharma.com
- Social LinkedIn
- Acquired by Covis Pharma (Oct 2020)
- Legal Name Covis Pharma Gmbh
- Investors
- Investments & AcquisitionsCord Blood Registry
& 3 more
- Acquired byCovis Pharma
(Oct 2020)
Products & Services of AMAG Pharma
AMAG Pharma offers a comprehensive portfolio of products and services, including Alvesco and Feraheme.
Alvesco is utilized for the treatment of asthma and other respiratory conditions in patients.
Feraheme is employed for addressing iron deficiency anemia in adult patients with chronic kidney disease.
Investors in AMAG Pharma
AMAG Pharma has secured backing from 1 investor. Prominent investors backing the company include Covis Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses | 2011 | covispharma.com | Zug, Switzerland |
Investor details for AMAG Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AMAG Pharma
23 people are tracked at AMAG Pharma (11 in leadership, 8 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Amy Y. | Associate Director, Compliance (global) | Leadership |
Erin L.w. Owusu | Associate Director Clinical Operations | Leadership |
Ann Denardis-Tomcko | Director Supply And Trade | Leadership |
Yuriy Shveda | Associate Director, Market Access US | Leadership |
Ayman Noaman | Executive Director, Head Of European Business Operations | Leadership |
Michael Porter | Chief Executive Officer | Leadership |
Lenis de Leon | Associate Director Govn't Pricing & GTN Analytics | Leadership |
Ron Clark | General Manager | Leadership |
Susan Lucas | Executive Director Market Access, Pricing, Contracting, Trade And Government Affairs | Leadership |
Daniel Freedman | VP of Clinical Operations | Leadership |
Albert Dahouk | Chief Information Officer | Leadership |
Rolf Hoffman | Advisor | Board & advisors |
Sean E. Brynjelsen | Advisor | Board & advisors |
Dhinusha Munien | Director | Board & advisors |
Taavi Davies | Director | Board & advisors |
John J. Kiely | Advisor | Board & advisors |
Claude Noesen | Director | Board & advisors |
Alexis Heinen | Director | Board & advisors |
Lucas Ellend-Brown | Advisor | Board & advisors |
Duilia Jiménez | Customer Service And Process Improvement Manager | Team |
3 more people are available in the full profile.
Complete people profiles for AMAG Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AMAG Pharma
AMAG Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cord Blood Registry, Lumara Health and Perosphere.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury. | perosphere.com | Mount Kisco, United States | 2011 | Jan 2019 | •••• | |
Novel small molecule agents for anticoagulant reversal are developed. | perospherepharma.com | Danbury, United States | 2011 | Dec 2018 | $415M | |
Cord blood and tissue stem cells are collected and preserved. | cordblood.com | Los Angeles, United States | 1992 | Jun 2015 | $700M | |
Medicines for women's health are developed by Lumara Health. | lumarahealth.com | St. Louis, United States | 1942 | Sep 2014 | $1.03B |
Complete acquisition details for AMAG Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of AMAG Pharma
7 dated milestones of AMAG Pharma across 39 years, from founding to its latest funding, stage changes and deals.
- Founded AMAG Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Lumara Health.
- Acquisition Acquires Cord Blood Registry.
- Acquisition Acquires Perosphere Pharmaceuticals.
- Acquisition Acquires Perosphere.
- Exit Acquired by Covis Pharma.
Web traffic of AMAG Pharma
Websites that share an audience with AMAG Pharma (amagpharma.com).
Websites whose visitors overlap most with AMAG Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| amylin.com | 100% | View details | |||
| shire.com | 87% | 1.4K | #14,679,892 | View details | |
| arraybiopharma.com | 87% | View details | |||
| lundbeck.com | 87% | 137.6K | #280,857 | View details | |
precisiontherapeutics.com | precisiontherapeutics.com | 87% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for AMAG Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as AMAG Pharma (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AMAG Pharma
AMAG Pharma was founded in 1981.
AMAG Pharma is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
AMAG Pharma was founded in 1981 and is headquartered in Waltham, United States. Operations focus on the pharmaceutical sector, where anemia-based products and diagnostic imaging agents are developed and commercialized. A therapeutic iron compound is produced to address iron deficiency anemia, alongside agents for cancer and cardiovascular disease diagnosis. Two approved products, Feraheme injection for intravenous use and GastroMARK, are manufactured and distributed.
AMAG Pharma offers Alvesco and Feraheme.
AMAG Pharma has made 4 acquisitions, including Cord Blood Registry, Lumara Health, and Perosphere.
AMAG Pharma has 1 investor. Key investors include Covis Pharma.
AMAG Pharma operates through Covis Pharma Gmbh.
Yes. AMAG Pharma was acquired by Covis Pharma in October 2020.